Shares of Palantir (NASDAQ: PLTR) spiked this week, finishing up 21.2% from last Friday's close. The jump comes as the S&P ...

This week, drugmakers had a scare when President Trump threatened to levy tariffs of up to 250% on imported pharmaceuticals.

OneStream's strong Q2, AI momentum, and attractive valuation amid a $50B TAM make the recent dip a buying opportunity. See why OS stock is upgraded to buy.